Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    "Vogt-Koyanagi-Harada syndrome"
Show Display Options
Rank Status Study
1 Completed Intravitreal Bevacizumab for Inflammatory Neovascular Membranes
Conditions: Vogt Koyanagi Harada Disease;   Serpiginous Choroiditis;   Multifocal Choroiditis
Interventions: Drug: Bevacizumab;   Procedure: Intravitreal Injection of Bevacizumab
2 Active, not recruiting Intravitreal Bevacizumab for the Treatment of CNV in VKH Disease - A Prospective Study
Condition: Choroidal Neovascularization
Intervention: Drug: bevacizumab

Indicates status has not been verified in more than two years